Literature DB >> 10372248

The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.

S E Moss1, R Klein, B E Klein.   

Abstract

OBJECTIVE: To estimate the cumulative 14-year incidence of lower-extremity amputations (LEAs) and evaluate risk factors for LEA. RESEARCH DESIGN AND METHODS: Study subjects consisted of population-based cohorts of younger-onset (diagnosed before age 30 years and taking insulin, n = 906) and older-onset (diagnosed after age 30 years, n = 984) individuals with diabetes. Subjects participated in baseline (1980-1982), 4-year, 10-year, and 14-year examinations or interviews. LEAs were determined by history.
RESULTS: The cumulative 14-year incidence of LEA was 7.2% in younger- and 9.9% in older-onset patients. In multivariable analyses based on the discrete linear logistic model, LEA in the younger-onset group was more likely for males (odds ratio [OR] 5.21 [95% CI 2.50-10.88]), older age (OR for 10 years 1.71 [1.30-2.24]), higher glycosylated hemoglobin (OR for 1% 1.39 [1.22-1.59]), higher diastolic blood pressure (OR for 10 mmHg 1.58 [1.20-2.07]), history of ulcers of the feet (3.19 [1.71-5.95]), and more severe retinopathy (OR for one step 1.16 [1.08-1.24]). In younger-onset patients aged > or = 18, pack-years smoked (OR for 10 years 1.20 [1.03-1.41]) was also associated with LEAs, and daily aspirin use was inversely associated (OR 0.11 [0.01-0.83]). In the older-onset group, LEA was more likely for men (2.66 [1.49, 4.76]) and if the subject had higher glycosylated hemoglobin (OR for 1% 1.25 [1.09-1.43]), higher pulse pressure (OR for 10 mmHg 1.19 [1.04-1.37]), history of ulcers (3.56 [1.84-6.89]), and more severe retinopathy (OR for one step 1.07 [1.00-1.13]).
CONCLUSIONS: There are several risk factors for LEA with potential for modification and preventive strategies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372248     DOI: 10.2337/diacare.22.6.951

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  27 in total

1.  Clinical outcomes of toe amputation in patients with type 2 diabetes in Tianjin, China.

Authors:  Yue-Jie Chu; Xi-Wen Li; Peng-Hua Wang; Jun Xu; Hao-Jie Sun; Min Ding; Jiao Jiao; Xiao-Yan Ji; Shu-hong Feng
Journal:  Int Wound J       Date:  2014-03-14       Impact factor: 3.315

2.  Remote Temperature Monitoring in Patients With Visual Impairment Due to Diabetes Mellitus: A Proposed Improvement to Current Standard of Care for Prevention of Diabetic Foot Ulcers.

Authors:  Amanda L Killeen; Kara M Brock; James F Dancho; Jodi L Walters
Journal:  J Diabetes Sci Technol       Date:  2019-05-23

Review 3.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

Review 4.  Vascular disease in the lower limb in type 1 diabetes.

Authors:  Michael Edmonds
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

5.  Microvascular Disease, Peripheral Artery Disease, and Amputation.

Authors:  Joshua A Beckman; Meredith S Duncan; Scott M Damrauer; Quinn S Wells; Joey V Barnett; David H Wasserman; Roger J Bedimo; Adeel A Butt; Vincent C Marconi; Jason J Sico; Hilary A Tindle; Marc P Bonaca; Aaron W Aday; Matthew S Freiberg
Journal:  Circulation       Date:  2019-07-08       Impact factor: 29.690

Review 6.  Reducing the incidence of foot ulceration and amputation in diabetes.

Authors:  Cynthia L Bartus; David J Margolis
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

7.  Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study.

Authors:  W A Davis; P E Norman; D G Bruce; T M E Davis
Journal:  Diabetologia       Date:  2006-09-26       Impact factor: 10.122

Review 8.  Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus-review and meta-analysis.

Authors:  A I Adler; S Erqou; T A S Lima; A H N Robinson
Journal:  Diabetologia       Date:  2010-02-03       Impact factor: 10.122

Review 9.  Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Authors:  Sergio Coccheri
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  A comparison of diabetic foot ulcer outcomes using negative pressure wound therapy versus historical standard of care.

Authors:  Lawrence A Lavery; Andrew J Boulton; Jeffrey A Niezgoda; Peter Sheehan
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.